Graft-Versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplant: SARS-CoV-2 Vaccine as a Potential Trigger

Allogeneic hematopoietic stem cell transplant (AHSCT) recipients are at a risk of developing immune-mediated tissue damage from activation of the donor’s immunocompetent T cells by the recipient’s normally expressed antigens, a phenomenon called graft-versus-host disease (GVHD). With the emergence o...

Descripción completa

Detalles Bibliográficos
Autores principales: Azem, Amin, Ajmal, Zainub, Raval, Mihir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262658/
https://www.ncbi.nlm.nih.gov/pubmed/35812599
http://dx.doi.org/10.7759/cureus.25738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262658/
https://www.ncbi.nlm.nih.gov/pubmed/35812599
http://dx.doi.org/10.7759/cureus.25738

Ejemplares similares